Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 2, 2026

GE Aerospace and Grupo Aeroportuario Del Pacifico have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
GE Aerospace and Grupo Aeroportuario Del Pacifico have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – February 2, 2026 – Zacks Equity Research shares GE Aerospace GE as the Bull of the Day and Grupo Aeroportuario Del Pacífico PAC as the Bear of the Day…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Meta's advertising revenues in 2025 increased 22.1% from 2024 to $196.18 billion, accounting for 97.6% of total revenues.

    80% confidence
  • GE's total backlog reached roughly $190 billion, up nearly $20 billion year-over-year, with Q4 orders up 74% to $27 billion.

    80% confidence
  • Meta Platforms holds a Zacks Rank #3 (Hold) rating.

    80% confidence
  • GAP's EPS is expected to be up 7% for FY25 and projected to increase another 27% in FY26 to $13.14 per share, but revisions are lower over the last 60 days.

    80% confidence
  • Meta, Alphabet, and Amazon are expected to absorb a majority of global ad spending by 2030.

    80% confidence
  • The consensus for GE's FY26 EPS has risen above its guidance range to $7.45 compared to $7.15 a week ago.

    80% confidence
  • GE has exceeded the Zacks EPS Consensus for 13 consecutive quarters, posting an average earnings surprise of 14.27% in its last four quarterly reports.

    80% confidence
  • Meta plans to complete the rollout of ads in WhatsApp Status throughout 2026.

    80% confidence
  • GAP's FY26 sales are projected to slow to a growth rate of 4%.

    80% confidence
  • GE's balance sheet carries over $12 billion in cash and $130 billion in total assets versus $111 billion in total liabilities.

    80% confidence
  • Meta's GEM model improvements drove a 3.5% lift in ad clicks on Facebook and more than 1% gain in conversions on Instagram in Q4 2025.

    80% confidence
  • GE Aerospace has soared over +280% in the last year and investors may be more inclined to pay a premium after a pullback from an all-time high of $332 a share in early January.

    80% confidence
  • PAC holds a Zacks Rank #5 (Strong Sell) rating.

    80% confidence
  • GE Aerospace's FY26 and FY27 EPS estimates have risen over 6% in the last two months.

    80% confidence
  • Grupo Aeroportuario Del Pacifico has missed bottom-line expectations for seven consecutive quarters with an average EPS surprise of -6% in its last four quarterly reports.

    80% confidence
  • Zacks top stock-picking strategies have achieved average gains of +48.4%, +50.2% and +56.7% per year since 2000 versus the S&P's +7.7% average annual gain.

    80% confidence
  • FY27 EPS projections of $8.55 would reflect 200% growth in five years compared to $2.81 per share in 2021.

    80% confidence
  • Meta shares climbed 6.6% in the trailing 12 months, underperforming the broader Zacks Computer and Technology sector's return of 27.8%.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
GE Aerospace and Grupo Aeroportuario Del Pacifico have been highlighted as Zacks Bull and Bear of the Day — Source | Via News | ViaNews Market